secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2022-09-12T23:59:59+00:00
Accession:  0001104659-22-099298
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Jeffrey B. McGroarty departs Annovis; severance includes 3-mo salary, 2-year option extension, stock sale lock-up
--------------------------------------------------------------------------------

- McGroarty's last day as CFO and employee was September 9, 2022; Henry Hagopian III named CFO earlier.
- Severance includes 3 months base salary, health coverage, and 2-year option exercise extension.
- McGroarty agrees to 24-month lock-up on stock sales; allows up to 100K shares per 6-month period with volume cap.
- Agreement includes non-solicitation, cooperation, non-disparagement, and general release of claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465922099298/0001104659-22-099298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465922099298/tm2225662d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-099298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer